Search

everythinglearnresearchcommunity

for

Search:↓

A thorough initial check-up is essential before sperm banking to ensure the best chance of preserving good quality sperm.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

Updated treatments for female hair loss include minoxidil, antiandrogens, hair transplants, and light therapy.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Some people experience lasting sexual, psychological, and sleep problems after using finasteride or SSRI antidepressants, possibly due to similar underlying causes.

Take care of your hair as much as your face for a youthful look.

Men with frontal male pattern baldness may have a higher risk of gastric cancer.

Older men and those with a history of skin cancer have a higher risk of getting skin cancer again.

Finasteride for hair loss increases risk of long-lasting sexual dysfunction.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

Balding men have higher heart disease risk.

Infertile men are more likely to produce sperm with abnormal chromosome numbers, which can affect pregnancy success and embryo health.

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

Testosterone is linked to cardiovascular risk factors and stroke, but its exact role is unclear.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Finasteride effectively stops hair loss in most patients, but concerns about rare sexual side effects exist.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Male pattern hair loss caused by follicular miniaturization; early diagnosis and treatment can reduce psychological burden.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

People distressed by minor skin changes should consult dermatologists with cosmetic expertise, and a public Cosmetic Dermatology Service with mental health support is recommended.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Vitamin D and estrogen may help protect heart and kidney health, and maintaining sufficient vitamin D levels could be especially beneficial for African Americans, postmenopausal women, and people with chronic kidney disease.

AGA is a common hair loss disorder, and early diagnosis and treatment with minoxidil or finasteride can help reduce emotional distress.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Testosterone replacement is recommended for men with low testosterone levels and symptoms of hypogonadism.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.